Advertisement
Home »

Blockade of the IL-22 Receptor: Novel Treatment Approach in AD

Mar 29, 2023

REFERENCES & ADDITIONAL READING

  1. Thaçi, D. Efficacy and safety of IL-22R inhibition in patients with moderate-to-severe atopic dermatitis: results from a Phase 2a monotherapy trial. S042, AAD Annual Meeting 2023, 17–21 March, New Orleans.

ABOUT THE CONTRIBUTORS

Author

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement